New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity and cardiovascular and fatty liver disease. The findings of the study in the Journal of Investigative Dermatology (JID), published by Elsevier, could lead to more targeted and effective treatments that address the systemic aspects of psoriasis, beyond just the skin.

Researchers in Japan have developed an AI model that objectively evaluates atopic dermatitis (AD) severity using smartphone images shared by patients on the country’s largest online AD platform. This technology could help patients monitor their condition more precisely at home and support timely treatment decisions.